2022 - How can Humanized Mouse Models be Used to Study Cancer & the Development of New Immune-Targeted Therapies?

In this webinar, the featured speakers will describe humanized immune system mouse models and how they can support preclinical drug development. The webinar will explore how humanized mouse models allow the assessment of immune-checkpoint inhibitors, cell therapies, vaccines or antibodies and other drugs.
First, speaker Sebastien Tabruyn will talk about the advantages of the humanized mouse models with human immune system (HIS) for immunology and oncology research and preclinical study techniques.
Next, speaker Wout de Wispelaere will present an application of humanized mice in the study of aggressive tumors: uterine leiomyosarcomas (uLMS) and a pathway to initiate an anti-tumor adaptive immune response.
Register to learn how humanized mouse models can be used to study cancer and the development of new immune-targeted therapies.